Provided by Tiger Trade Technology Pte. Ltd.

Taysha Gene Therapies, Inc.

4.63
-0.1100-2.32%
Post-market: 4.630.00000.00%19:30 EDT
Volume:2.99M
Turnover:14.05M
Market Cap:1.51B
PE:-11.22
High:4.86
Open:4.80
Low:4.63
Close:4.74
52wk High:7.30
52wk Low:3.69
Shares:325.83M
Float Shares:233.00M
Volume Ratio:0.59
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4126
EPS(LYR):-0.3409
ROE:-47.05%
ROA:-23.82%
PB:3.90
PE(LYR):-13.58

Loading ...

Taysha Gene Therapies Price Target Maintained with a $11.00/share by Citizens

Dow Jones
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Taysha Gene Therapies (TSHA) and Zymeworks (ZYME)

TIPRANKS
·
Jul 01

Taysha Gene Therapies is Maintained at Outperform by Baird

Dow Jones
·
Jun 30

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 30

Taysha Gene Therapies Posts Reveal Part a Phase 1/2 Tsha-102 Rett Syndrome Trial Presentation

Reuters
·
Jun 29

Taysha Gene Therapies Announces Major Equity Financing Deal

TIPRANKS
·
Jun 26

Taysha Gene Therapies Announces Multiple Presentations Highlighting Its Tsha-102 Clinical Program at the 2026 Irsf Rett Syndrome Scientific Meeting

THOMSON REUTERS
·
Jun 26

Taysha Gene Therapies to Present Reveal Phase 1/2 Data for Rett Gene Therapy Tsha-102 at 2026 IRSF Meeting

Reuters
·
Jun 26

Taysha Gene Therapies management to meet with Piper Sandler

TIPRANKS
·
Jun 26

Taysha Gene Therapies Down over 11%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
Jun 26

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires Live
·
Jun 25

Taysha Gene Therapies 32.5M share Spot Secondary priced at $6.00

TIPRANKS
·
Jun 25

Taysha Gene Therapies - Prices Offering of 32.5 Mln Shares at $6 Each

THOMSON REUTERS
·
Jun 25

Taysha Gene Therapies Inc: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Jun 25

Taysha Gene Therapies announces $200M common stock offering

TIPRANKS
·
Jun 25

Taysha Gene Therapies Launches USD 200 Million Common Stock, Pre-funded Warrants Offering

Reuters
·
Jun 25

Taysha Gene Therapies Inc: Commenced an Underwritten Public Offering of $200.0 Mln Shares of Its Common Stock and Pre-funded Warrants

THOMSON REUTERS
·
Jun 25

Jefferies Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)

TIPRANKS
·
Jun 23

Taysha Gene Therapies price target raised to $11 from $8 at Citizens

TIPRANKS
·
Jun 23

Taysha Gene Therapies Is Maintained at Buy by Needham

Dow Jones
·
Jun 23